Dhruvajyoti Roy, Ph.D., is the Director of Technology of Laboratory for Advanced Medicine (LAM), where he focuses on the development of epigenetic markers for the early detection of cancer from liquid biopsy samples. Dr. Roy received his Ph.D. in Chemistry and Nanobiotechnology from the Pohang University of Science and Technology (POSTECH) in South Korea. Before joining LAM, Dr. Roy served as a lead scientist and directed multiple research projects as a key research scientist for collaborations with multi-disciplinary research/scientific teams and professionals including major pharmaceutical and diagnostic companies. Roy’s work has contributed significantly to the advancement of cancer diagnostics and biomarkers, with a special focus on the use of bionanotechnology and surface chemistry for the detection of biomarkers. Roy is a member of the American Society of Clinical Oncology (ASCO), a senior member of the IEEE and Sigma Xi member of the Scientific Research Honor Society. He is associated with several prestigious peer-reviewed journals as a reviewer, editor and editorial board member, including Langmuir, Lab on a Chip, Analytical and Bioanalytical Chemistry, Journal of Biosensors Biomarkers and Diagnostics, Molecular Cancer Therapeutics, Clinical Cancer Research, and others.